Omada Health, Inc. is a U.S.-based virtual care company that delivers evidence-based programs for chronic conditions through a human-led, technology-enabled care model. Its platform supports members between doctor visits across cardiometabolic and musculoskeletal care, with programs sold directly to employers and through health plans, PBMs, and health systems.
−2,5 %
65,7 %
−4,9 %
+53,2 %
3.60
3.54
| % | |
|---|---|
| Cardiometabolic virtual care | 55% Programs for diabetes, hypertension, and related metabolic risk conditions delivered through ongoing member support. |
| Prevention & Weight Health | 25% Behavior-change and weight-management programs aimed at prevention and metabolic health improvement. |
| GLP-1 support services | 10% Companion services and prescribing-related support for members using obesity medications. |
| Musculoskeletal care | 10% Virtual care programs focused on MSK conditions and related member support. |
Omada sells on a business-to-business-to-consumer basis, with customers that cover programs for employees, dependents,...
Buy Omada programs for employees and dependents to manage chronic disease and weight-related risk.
Purchase directly or act as channel partners to offer Omada to covered lives and employer groups.
Resell Omada programs or cover them directly for members as part of broader benefit offerings.
Use Omada for patients in risk-bearing arrangements where reducing downstream cost matters.
Emerging buyer base for broader covered-life expansion and new distribution channels.
Omada is headquartered in the United States and its business is primarily organized around U.S...
Omada’s strategy centers on expanding covered lives by adding new customers, deepening relationships with existing...
Selling additional programs into existing accounts raises revenue per customer and improves retention.
More enrolled and active members directly increase services revenue and improve customer outcomes.
Health plans and PBMs extend reach into employer and member populations at lower sales friction.
The obesity market is evolving, and customers want support across medication and non-medication pathways.
Omada depends on customers and channel partners recognizing clinical and economic value, so adoption risk is closely...
A large share of revenue comes from a small number of health plan and PBM partners, increasing renewal and pricing risk.
If customers do not believe the programs reduce cost or improve outcomes, market adoption can slow materially.
The company handles PHI and other sensitive data, so breaches or outages could disrupt operations and create liability.
Contracts may require repayment of fees if engagement, outcomes, or savings targets are not met.
Connected devices are part of cardiometabolic programs and are largely manufactured in China, creating cost and supply risk.
: 29.4.2026